- Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
Abderrahim El Guerrab et al, 2020, Sci Rep CrossRef - Colon cancer – new strategies of treatment
Anna Międzybrodzka et al, 2019, Ann. Acad. Med. Siles. CrossRef - SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
Wenwen Geng et al, 2023, Cancer Biology & Therapy CrossRef